Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash

Por Weiss, Lilia, Gary, Dianna, Swern, Arlene S, Freeman, John, Sugrue, Mary M
Publicado no Ther Clin Risk Manag (2015)

Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma

Por Chanan-Khan, Asher A., Lonial, Sagar, Weber, Donna, Borrello, Ivan, Foá, Robin, Hellmann, Andrzej, Dimopoulos, Meletios, Swern, Arlene S., Knight, Robert
Publicado em 2012

Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis

Por Williams-Herman, Debora, Round, Elizabeth, Swern, Arlene S, Musser, Bret, Davies, Michael J, Stein, Peter P, Kaufman, Keith D, Amatruda, John M
Publicado em 2008

Perceptions of Disease State, Treatment Outcomes, and Prognosis Among Patients with Myelodysplastic Syndromes: Results from an Internet-Based Survey

Por Sekeres, Mikkael A., Maciejewski, Jaroslaw P., List, Alan F., Steensma, David P., Artz, Andrew, Swern, Arlene S., Scribner, Paul, Huber, John, Stone, Richard
Publicado em 2011

A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care...

Por Gore, Steven D., Fenaux, Pierre, Santini, Valeria, Bennett, John M., Silverman, Lewis R., Seymour, John F., Hellström-Lindberg, Eva, Swern, Arlene S., Beach, Charles. L., List, Alan. F.
Publicado em 2013

Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States

Por Nabhan, Chadi, Mato, Anthony, Flowers, Christopher R., Grinblatt, David L., Lamanna, Nicole, Weiss, Mark A., Davids, Matthew S., Swern, Arlene S., Bhushan, Shriya, Sullivan, Kristen, Flick, E. Dawn, Kiselev, Pavel, Sharman, Jeff P.
Publicado no BMC Cancer (2017)

Real‐world clinical experience in the Connect(®) chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres

Por Mato, Anthony, Nabhan, Chadi, Kay, Neil E., Weiss, Mark A., Lamanna, Nicole, Kipps, Thomas J., Grinblatt, David L., Flinn, Ian W., Kozloff, Mark F., Flowers, Christopher R., Farber, Charles M., Kiselev, Pavel, Swern, Arlene S., Sullivan, Kristen, Flick, E. Dawn, Sharman, Jeff P.
Publicado no Br J Haematol (2016)

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study

Por Steensma, David P., Abedi, Medrdad, Bejar, Rafael, Cogle, Christopher R., Foucar, Kathryn, Garcia-Manero, Guillermo, George, Tracy I., Grinblatt, David, Komrokji, Rami, Ma, Xiaomei, Maciejewski, Jaroslaw, Pollyea, Daniel A., Savona, Michael R., Scott, Bart, Sekeres, Mikkael A., Thompson, Michael A., Swern, Arlene S., Nifenecker, Melissa, Sugrue, Mary M., Erba, Harry
Publicado no BMC Cancer (2016)

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Aust...

Por Pleyer, Lisa, Döhner, Hartmut, Dombret, Hervé, Seymour, John F., Schuh, Andre C., Beach, CL, Swern, Arlene S., Burgstaller, Sonja, Stauder, Reinhard, Girschikofsky, Michael, Sill, Heinz, Schlick, Konstantin, Thaler, Josef, Halter, Britta, Machherndl Spandl, Sigrid, Zebisch, Armin, Pichler, Angelika, Pfeilstöcker, Michael, Autzinger, Eva M., Lang, Alois, Geissler, Klaus, Voskova, Daniela, Sperr, Wolfgang R., Hojas, Sabine, Rogulj, Inga M., Andel, Johannes, Greil, Richard
Publicado no Int J Mol Sci (2017)